Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Florida Weight Loss MD vs Spry

Florida Weight Loss MD
Graded #329

Higher grade

vs+3.3000000000000043
Spry
Graded #408

Lower grade

The verdict

Florida Weight Loss MD takes it — 60.1/100 to 56.8/100.

Florida Weight Loss MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Florida Weight Loss MD (Florida Surgery & Weight Loss Center) is a physician-led telehealth clinic serving patients statewide across Florida.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSpry +3
51
54
Dose & formulationSpry +11
53
64
Clinical oversightFlorida Weight Loss MD +23
78
55
Labs & monitoringFlorida Weight Loss MD +10
62
52
FulfillmentFlorida Weight Loss MD +6
67
61
Contract termsSpry +8
47
55
Florida Weight Loss MD · left barSpry · right bar

The numbers

MetricFlorida Weight Loss MDSpry
WeighScore60.1/10056.8/100
GradeCC
Scorecard rank#329#408
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$299/mo (starting dose, compounded)
Coverage1 stateCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Florida Weight Loss MD

Graded #329 · C

Strengths

  • Physician-led (Dr. Sergey Terushkin, MD, FACS) with same-day telehealth visits statewide in Florida
  • Offers both compounded GLP-1 and brand Wegovy/Ozempic/Mounjaro/Zepbound when appropriate
  • Accepts most insurance or self-pay; consult $99 with $49 applied to the program

Where it loses points

  • Florida residents only — no service outside the state
  • Monthly medication pricing is not published; disclosed after evaluation
  • Single-clinic operation rather than a national telehealth platform
Spry

Graded #408 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard